Impact of Intravitreal Injection of Bevacizumab (Avastin) on Rabbit's Choroid and Retina
2008

Impact of Bevacizumab Injection on Rabbit Eyes

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): Karawya Sherif MD, Said Dalia G. MD, Salaheldin Mostafa M. MD, Zaky Iman MD

Primary Institution: Research Institute of Ophthalmology, Cairo, Egypt

Hypothesis

The study aimed to evaluate the impact of intravitreal injection of bevacizumab (Avastin) on chorio-capillaris permeability and structural changes in the choroid and retina of pigmented rabbits.

Conclusion

A single intravitreal injection of Avastin does not cause significant histological changes in rabbit retina and choroid, but it does affect chorio-capillaris permeability.

Supporting Evidence

  • 70% of eyes injected with Avastin showed decreased chorio-capillaris fluorescence.
  • Histological examination revealed no significant changes in the retina and choroid.
  • TEM examination confirmed reduced fenestrations in chorio-capillaris endothelial cells.

Takeaway

The study tested a medicine called Avastin in rabbits' eyes and found it didn't hurt their eyes but changed how some tiny blood vessels worked.

Methodology

The study involved 10 pigmented rabbits, with intravitreal injections of Avastin in one eye and balanced salt solution in the other, followed by clinical and histological examinations.

Limitations

The study was limited to a small sample size of rabbits and focused on short-term effects.

Participant Demographics

10 pigmented rabbits, weighing between 1.2 and 2 kg.

Digital Object Identifier (DOI)

10.4103/0974-9233.51995

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication